Literature DB >> 33756444

The use of post-anaesthesia care units as a supply of ICU beds while maintaining scheduled surgery: A cross-sectional web-based feasibility survey in France.

Thomas Clavier1, Vincent Bruckert2, Paul Abraham3, Mathieu Capdevila4, Arthur James5.   

Abstract

Entities:  

Mesh:

Year:  2021        PMID: 33756444      PMCID: PMC7980666          DOI: 10.1016/j.jclinane.2021.110244

Source DB:  PubMed          Journal:  J Clin Anesth        ISSN: 0952-8180            Impact factor:   9.375


× No keyword cloud information.
Dear Editor, One year after the emergence of the coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the global outbreak led to over 77 million infections, 2,500,000 deaths worldwide, and has remained a major public health issue. This new pandemic has increased the inflow of new intensive care unit (ICU) patients, which at times overwhelmed many Hospitals' surge capacity. Outside a pandemic context, the volume of ICU beds is tailored to the population's needs. However, following the COVID-19 pandemic, conventional ICU beds were quickly filled up and new makeshift ICUs were built up in many countries around the world [1,2]. In most cases, the opening of these ICUs was only temporary, in order to cope with the successive COVID-19 outbreaks. However, as future outbreaks and their nature are still unknown, it remains challenging to accurately estimate the upcoming needs for ICU beds while maintaining optimal care and access for all patients [3]. Yet, creating new permanent ICU beds takes time, remains costly, requires specialized staff recruitment and may prove superfluous in the absence of a subsequent pandemic recurrence. In France, physicians and nurses trained in both Anaesthesiology and Critical Care Medicine have been on the front line since the beginning of the COVID-19 pandemic [1,4]. They are highly skilled in providing mechanical ventilation, invasive procedures, and administering specific ICU drugs (neuromuscular blocking agents, sedatives, vasopressors, etc.). Therefore, they represent a critical and readily available workforce for the staffing of newly created ICUs and the provision of quality intensive care for the critically ill patients, whether they suffer from COVID-19 or other severe conditions. The COVID-19 pandemic has also taught healthcare providers that a sudden ICU surge may impede scheduled procedures and impose deleterious therapeutic delays for many patients. Thus, it appears essential to maintain scheduled surgery even during a pandemic period or during a sudden inflow of ICU patients [5]. Post-anaesthesia care units (PACU) and ICUs share common foundations, including high-end equipment and skilled healthcare professionals working under medical supervision. Nurses working in the PACU (whether anaesthesia or ICU nurses) are also familiar with mechanical ventilation, monitoring intubated patients, and administering ICU-specific medications. Although this is not their general purpose, PACUs may be customized to ICU patient care. The use of beds available in the PACU could therefore buffer a temporary overload of critically-ill patients, obviating the need to open new ICUs and limiting the risk of surgical cancellations. We therefore hypothesized that the French healthcare system, equipped with many PACUs that take care of patients around the clock, may possess the required supplementary ICU resources to cope with a sudden ICU surge, without downsizing scheduled surgical procedures. To test this hypothesis, we conducted a survey using administrative electronic database to contact all anaesthesiologists in charge of a PACU in France (IRB: 10254–2021-045, no consent required to participate in the survey). Since PACUs are often open wards, it could be considered suboptimal and not safe to offer PACU beds to contagious COVID-19 patients. Therefore, each survey respondent was asked how many non-COVID patients requiring critical care could be admitted in her/his PACU without impacting the operating room schedule. Consequently, their estimation was based on their PACU bed occupancy rate during non-pandemic periods. 677 surveys have been sent to head of department of anaesthesiology of hospitals where an ICU or intermediate care unit and a PACU are present. 225 of them (33%) responded. The responding anaesthesiologists estimated that 540 ICU patients could be admitted in these PACU beds without any change in surgical activities. Among responding centres, 73 (32%) reported being unable to accept any ICU patients. Among responding centres, 32% (n=73) reported being unable to accept any ICU patients. It was estimated by the respondents that 1585 patients could be admitted in their PACU on the condition that a reduction of current surgical activities was allowed. Detailed description of the PACU is reported in Table 1 , while geographic locations of these PACUs in France is presented in Fig. 1 .
Table 1

Responding post-anaesthesia care unit description.

Responding PACU (n = 225)
Type of structure
 Public university hospital73 (32.7%)
 Public non-academic hospital64 (28.7%)
 Private hospital86 (38.5%)
 NA2 (0.01%)
Bed in ICU (/hospital)12 [0, 24]
Bed in step down units (/hospital)8 [6, 14]
Number of PACU in the hospital1.00 [1.00, 3.00]
PACU beds
 Total number of beds during the day16 [10, 24]
 Number of beds open 24 h/244 [0, 9]
Number of ICU patients who could be admitted to PACU
 Without impacting scheduled surgery2 [0, 4]
 NA35
 With an impact on scheduled surgery6 [3,10]
 NA19
Resources
 ICU physician195 (87.5)
 Nurses and other care givers1 [0,2]
 Ventilators6 [3,11]

Data are presented as median [interquartile range] and absolute value (%). ICU, intensive care unit; PACU, post-anaesthesia care unit.

Fig. 1

Responding post-anaesthesia care unit capacities for ICU patients' admission without impact on scheduled surgery (by department).

Number of PACU beds available for non-COVID ICU patients without impacting scheduled surgery. Department without responses are reported in grey. ICU, intensive care unit; PACU, post-anaesthesia care unit.(For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)

Responding post-anaesthesia care unit description. Data are presented as median [interquartile range] and absolute value (%). ICU, intensive care unit; PACU, post-anaesthesia care unit. Responding post-anaesthesia care unit capacities for ICU patients' admission without impact on scheduled surgery (by department). Number of PACU beds available for non-COVID ICU patients without impacting scheduled surgery. Department without responses are reported in grey. ICU, intensive care unit; PACU, post-anaesthesia care unit.(For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.) These results suggest that PACU beds are immediately available resources for crisis management at a national level while maintaining a normal elective surgical activity. This strategy has several strengths: no additional costs related to the opening of new ICU beds, no need to cancel surgical or interventional procedures, no need to create a temporary ICU structure, and no need for accelerated training of unskilled staff for clinical care. As expected, a large proportion of the potentially available PACU beds are located in the most populous regions in France, where many busy hospitals function day and night (Lille, Nantes, Paris, Lyon, Marseille, Bordeaux, Strasbourg; see Fig. 1). However, similar to most web-based surveys, the main limitation of this study lies in its design with the potential lack of response and reporting bias. Given that there are approximately 1000 hospitals in France which provide surgical care, the estimated proportion of responding services probably did not exceed 30% of the global national PACU capacity. We therefore report a minimal volume of available PACU beds for ICU patients in France. Moreover, our results only apply to the French settings, but it may be worthwhile to assess the feasibility of this strategy in other European countries. In conclusion, a strategy allowing a quick increase in ICU surge capacity based on selected PACU beds appears feasible in France without impacting scheduled surgery.

Declaration of Competing Interest

The authors declare that they have no competing conflict of interest.
  5 in total

1.  All-Cause Excess Mortality and COVID-19-Related Mortality Among US Adults Aged 25-44 Years, March-July 2020.

Authors:  Jeremy Samuel Faust; Harlan M Krumholz; Chengan Du; Katherine Dickerson Mayes; Zhenqiu Lin; Cleavon Gilman; Rochelle P Walensky
Journal:  JAMA       Date:  2021-02-23       Impact factor: 56.272

2.  Urgent development of an anaesthesiology-based intensive care unit for critical COVID-19 infected patients.

Authors:  Hakim Harkouk; Chantal Jacob; Dominique Fletcher
Journal:  Anaesth Crit Care Pain Med       Date:  2020-05-04       Impact factor: 4.132

3.  A national healthcare response to intensive care bed requirements during the COVID-19 outbreak in France.

Authors:  Jean-Yves Lefrant; Marc-Olivier Fischer; Hugo Potier; Cécile Degryse; Samir Jaber; Laurent Muller; Julien Pottecher; Hélène Charboneau; Eric Meaudre; Pierre Lanot; Vincent Bruckert; Benoît Plaud; Bertrand Dureuil; Emmanuel Samain; Hervé Bouaziz; Claude Ecoffey; Xavier Capdevila
Journal:  Anaesth Crit Care Pain Med       Date:  2020-10-05       Impact factor: 4.132

Review 4.  A systematic review and meta-analysis of surgery delays and survival in breast, lung and colon cancers: Implication for surgical triage during the COVID-19 pandemic.

Authors:  Brett A Johnson; Anthony C Waddimba; Gerald O Ogola; James W Fleshman; John T Preskitt
Journal:  Am J Surg       Date:  2020-12-08       Impact factor: 2.565

5.  Spatiotemporal analysis of medical resource deficiencies in the U.S. under COVID-19 pandemic.

Authors:  Dexuan Sha; Xin Miao; Hai Lan; Kathleen Stewart; Shiyang Ruan; Yifei Tian; Yuyang Tian; Chaowei Yang
Journal:  PLoS One       Date:  2020-10-14       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.